Antitumor Imidazotetrazines. 40. Radiosyntheses of [4-11C-Carbonyl]- and [3-N-11C-Methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (Temozolomide) for Positron Emission Tomography (PET) Studies-Reference-Cited by-同舟云学术

Antitumor Imidazotetrazines. 40. Radiosyntheses of [4-11C-Carbonyl]- and [3-N-11C-Methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (Temozolomide) for Positron Emission Tomography (PET) Studies

Published:2002-11-05 Issue:25 Volume:45 Page:5448-5457
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Brown Gavin D.¹,Luthra Sajinder K.¹,Brock Cathryn S.¹,Stevens Malcolm F. G.¹,Price Patricia M.¹,Brady Frank¹

Affiliation:

1. MRC Clinical Sciences Centre, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK, Imaging Research Solutions Ltd, Cyclotron Building, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK, and Cancer Research Laboratories, School of Pharmaceutical Sciences, University of Nottingham, Nottingham NG7 2RD

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm020921f

Reference39 articles.

1. Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide

2. The charing cross hospital experience with temozolomide in patients with gliomas

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gas Phase Transformations in Carbon-11 Chemistry;International Journal of Molecular Sciences;2024-01-18

2. [11C]CO2 BOP fixation with amines to access 11C‐labeled ureas for PET imaging;Journal of Labelled Compounds and Radiopharmaceuticals;2023-12-10

3. Intracerebral Distribution of CAG Repeat-Binding Small Molecule Visualized by Whole-Brain Imaging;Bioconjugate Chemistry;2023-11-10

4. Antitumour imidazotetrazines: past, present… and future?;RSC Chemical Biology;2023

5. Anticancer alkylating agents;New Strategies Targeting Cancer Metabolism;2022